Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 75 holding rows worth $243,521,000.

Accession
0001389933-18-000012
Filed
2018-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 75 entries on the cover page, a total value of $243,521,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $243,521,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LOXO ONCOLOGY INC548862101COM169,675$28,986,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK13,680,554$16,553,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM99,306$14,027,000thousands by filing date
ATRICURE INC04963C209COM293,729$10,289,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK306,119$8,538,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM132,770$8,172,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM92,691$7,235,000thousands by filing date
ZOGENIX INC.98978L204Common Stock138,264$6,858,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM396,013$6,594,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK625,738$5,525,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR77,242$5,473,000thousands by filing date
DEXCOM INC COM252131107Stock37,000$5,292,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM41,008$5,042,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO260,336$5,038,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock652,086$4,975,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR64,300$4,877,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS808,000$4,630,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW98,547$4,535,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR39,609$4,453,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock240,500$4,209,000thousands by filing date
LUMINEX CORP55027E102COMMON STOCK138,391$4,195,000thousands by filing date
IMMUNOMEDICS INC452907108COM178,000$3,708,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM294,511$3,263,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH26,100$3,183,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock237,683$3,137,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM847,636$3,119,000thousands by filing date
RADIUS HEALTH INC750469AA6NOTE4,000,000$3,080,000thousands by filing dateprincipal
MENLO THERAPEUTICS INC586858102COM312,000$3,073,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS537,000$3,034,000thousands by filing date
BIOTELEMETRY INC090672106COM46,800$3,016,000thousands by filing date
BLUEBIRD BIO INC09609G100COM20,500$2,993,000thousands by filing date
CARA THERAPEUTICS INC140755109COM112,811$2,702,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM359,860$2,627,000thousands by filing date
ARQULE INC04269E107COM447,664$2,534,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock47,900$2,395,000thousands by filing date
VBI VACCINES INC91822J103COM NEW934,691$2,262,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK56,200$2,200,000thousands by filing date
ARDELYX INC039697107COM472,859$2,057,000thousands by filing date
INSULET CORP45784PAG6NOTE 1.375%1,500,000$1,909,000thousands by filing dateprincipal
DICERNA PHARMACEUTICALS INC253031108COM118,500$1,808,000thousands by filing date
MACROGENICS INC556099109COM78,305$1,679,000thousands by filing date
ADVAXIS INC007624208COM NEW1,666,666$1,567,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock1,272,927$1,528,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock151,739$1,517,000thousands by filing date
INCYTE CORP COM45337C102Stock21,500$1,485,000thousands by filing date
NATUS MEDICAL INC639050103COM37,900$1,351,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK700,000$1,316,000thousands by filing date
Johnson & Johnson478160104COM9,400$1,299,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock328,500$1,133,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM30,000$1,127,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM140,643$1,096,000thousands by filing date
ZAFGEN INC98885E103COM85,842$1,003,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock212,766$936,000thousands by filing date
ObsEva SAH5861P103COM43,338$781,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM373,702$747,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM70,000$736,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK15,000$708,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW62,690$617,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK137,600$442,000thousands by filing date
NEON THERAPEUTICS INC64050Y100COM50,000$427,000thousands by filing date
APTINYX INC03836N103COM14,500$420,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM27,494$412,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM10,673$396,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM17,725$392,000thousands by filing date
DEXCOM INC252131AF4NOTE 0.750% 5/1250,000$383,000thousands by filing dateprincipal
MASIMO CORP COM574795100Stock3,000$374,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW20,500$365,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock26,907$338,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339AA3NOTE 2.500% 2/0250,000$269,000thousands by filing dateprincipal
SOL GEL TECHNOLOGIESM8694L103SHS35,000$263,000thousands by filing date
Bowater Inc09066L105COMMON STOCKS100,000$235,000thousands by filing date
KADMON HLDGS INC48283N106COM63,000$210,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM30,000$185,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM27,500$133,000thousands by filing date
DERMIRA INC24983L104COM5,000$55,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-18-000012this filing2018-11-14acceptance time not in the bulk data set